2-氨基-5-碘苯甲酸乙酯 | 268568-11-2

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-5-碘苯甲酸乙酯
• 英文名称: ethyl 2-amino-5-iodobenzoate
• CAS: 268568-11-2
• 化学式: C₉H₁₀INO₂
• 分子量: 291.088
• InChiKey: FPCLHSGOJPEKKE-UHFFFAOYSA-N

物化性质

• 熔点：
  69-71°C
• 沸点：
  347.9±32.0 °C(Predicted)
• 密度：
  1.730
• 稳定性/保质期：

  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  4002191900
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  保存方法：密封、阴凉、通风干燥处

反应信息

• 作为反应物：
  描述：

  2-氨基-5-碘苯甲酸乙酯 在 吡啶 、 potassium hydride 、 溶剂黄146 、 二甲基亚砜 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 10.0h， 生成 2-iodo,9-trifluoromethyl-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one
  参考文献：
  名称：

  2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity

  摘要：

  9-Trifluoromethyl-paullones with a carbon chain in the 2-position were synthesized by palladium-catalyzed coupling reactions of a 2-iodoprecursor with terminal alkenes or alkynes, respectively. The introduction of a 2-cyanoethyl substituent led to a significant enhancement of CDK1/cyclin B inhibiting property and in vitro antiproliferative activity. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00048-2
• 作为产物：
  描述：

  2-氨基苯甲酸乙酯 在 碘 、 silver sulfate 作用下， 以 乙醇 为溶剂， 反应 1.0h， 以90%的产率得到2-氨基-5-碘苯甲酸乙酯
  参考文献：
  名称：

  Hydrogen bonding-mediated self-assembly of square and triangular metallocyclophanes

  摘要：

  Intramolecular three-centered hydrogen bonding has been used to induce dipyridyl anthranilamide 5 and diphenylacetylene anthranilamide 11 to adopt rigid straight conformation. Compound 5 reacted with Pd(dppp)(OTf)(2) (12a) or Pt(dppp)(OTf)(2) (12b) in dichloromethane to afford square metallocyclophanes 13a and 13b in 70% and 40% yield, respectively. In contrast, the reaction of 11 with 12b in dichloromethane gave triangular metallocyclophane 14 in 15% yield. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2005.06.173

文献信息

• [EN] (2-((2-ALKOXY) -PHENYL) -CYCLOPENT-1-ENYL) AROMATIC CARBO AND HETEROCYCLIC ACID AND DERIVATIVES<br/>[FR] ACIDE (2-((2-ALCOXY) -PHENYL) -CYCLOPENT-1-ENYL) AROMATIQUE CARBOCYCLIQUE AND HETEROCYCLIQUE ET SES DERIVES
  申请人：GLAXO GROUP LTD

  公开号：WO2003084917A1

  公开（公告）日：2003-10-16

  Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: (I) wherein A, R1 , R2 , Rx , R8 , R9 and n are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

  式(I)或其药学上可接受的衍生物的化合物：其中A、R1、R2、Rx、R8、R9和n如规范中所定义，一种制备这种化合物的方法，包括这种化合物的药物组合物以及这种化合物在医学上的用途。
• Palladium-catalyzed direct arylation using free NH2 substituted thiophene derivatives with inhibition of amination type reaction
  作者：Fazia Derridj、Karima Si Larbi、Julien Roger、Safia Djebbar、Henri Doucet

  DOI：10.1016/j.tet.2012.06.053

  日期：2012.9

  The palladium-catalyzed direct arylation at C2 or C5 of free NH2 substituted thiophene derivatives was found to proceed in moderate to high yields using a variety of aryl halides. The choice of potassium acetate as the base was found to be crucial to inhibit the amination reaction and to promote the direct arylation.

  发现使用各种芳基卤化物，钯催化的游离NH 2取代的噻吩衍生物在C2或C5处的直接芳基化反应以中等至高收率进行。发现选择乙酸钾作为碱对于抑制胺化反应和促进直接芳基化至关重要。
• Palladium-Catalyzed Oxidative Coupling of Trialkylamines with Aryl Iodides Leading to Alkyl Aryl Ketones
  作者：Yan Liu、Bo Yao、Chen-Liang Deng、Ri-Yuan Tang、Xing-Guo Zhang、Jin-Heng Li

  DOI：10.1021/ol200404z

  日期：2011.5.6

  A new, simple method for selectively synthesizing alkyl aryl ketones has been developed by palladium-catalyzed oxidative coupling of trialkylamines with aryl iodides. In the presence of PdCl2(MeCN)2, TBAB, and ZnO, a variety of aryl iodides underwent an oxidative coupling reaction with tertiary amines and water to afford the corresponding alkyl aryl ketones in moderate to excellent yields. It is noteworthy

  通过钯催化三烷基胺与芳基碘化物的氧化偶联，已经开发出一种选择性合成烷基芳基酮的新的简单方法。在PdCl 2（MeCN）2，TBAB和ZnO的存在下，各种芳基碘化物与叔胺和水进行氧化偶联反应，以中等至极好的收率得到相应的烷基芳基酮。值得注意的是，该方法是使用三烷基胺作为羰基来源构建烷基芳基酮骨架的第一个例子。
• RE[N(SiMe₃)₂]₃-Catalyzed Guanylation/Cyclization of Amino Acid Esters and Carbodiimides
  作者：Chengrong Lu、Chao Gong、Bei Zhao、Lijuan Hu、Yingming Yao

  DOI：10.1021/acs.joc.7b02550

  日期：2018.2.2

  The example of rare-earth metal-catalyzed guanylation/cyclization of amino acid esters and carbodiimides is well-established, forming 4(3H)-2-alkylaminoquinazolinones in 65–96% yields. The rare-earth metal amides RE[N(TMS)2]3 (RE = Y, Yb, Nd, Sm, La; TMS = SiMe3) showed high activities, and La[N(TMS)2]3 performed best for a wide scope of the substrates.

  稀土金属催化氨基酸酯和碳二亚胺的鸟苷酸化/环化的例子是公认的，以65-96％的产率形成4（3 H）-2-烷基氨基喹唑啉酮。稀土金属酰胺RE [N（TMS）2 ] 3（RE = Y，Yb，Nd，Sm，La; TMS = SiMe 3）表现出高活性，而La [N（TMS）2 ] 3表现最好。广泛的基材。
• (2-((2-alkoxy)-phenyl)-cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
  申请人：Giblin Paul Gerard Martin

  公开号：US20050239802A1

  公开（公告）日：2005-10-27

  Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R 1 , R 2 , R x , R 8 , R 9 and n are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

  公式（I）的化合物或其药学上可接受的衍生物：其中A，R1，R2，Rx，R8，R9和n如规范中所定义，制备这种化合物的过程，包括这种化合物的制药组合物以及在医学中使用这种化合物的用途。